12.48
price down icon0.48%   -0.06
after-market  After Hours:  12.12  -0.36   -2.88%
loading
R1 RCM Inc. stock is currently priced at $12.48, with a 24-hour trading volume of 1.56M. It has seen a -0.48% decreased in the last 24 hours and a +0.40% rose in the past month. The chart indicates a potential bearish trend, as the stock is below the $12.49 pivot point. If it approaches the $12.35 support level, significant changes may occur.
Previous Close:
$12.54
Open:
$12.45
24h Volume:
1.56M
Market Cap:
$5.26B
Revenue:
$2.31B
Net Income/Loss:
$-33.40M
P/E Ratio:
-145.45
EPS:
-0.0858
Net Cash Flow:
$228.60M
1W Performance:
-0.56%
1M Performance:
+0.40%
6M Performance:
+19.31%
1Y Performance:
-27.78%
1D Range:
Value
$12.34
$12.57
52W Range:
Value
$8.87
$18.70

R1 RCM Inc. Stock (RCM) Company Profile

Name
Name
R1 RCM Inc.
Name
Phone
312-324-7820
Name
Address
401 North Michigan Avenue, Suite 2700, Chicago, IL
Name
Employee
9,065
Name
Twitter
@r1rcm
Name
Next Earnings Date
2023-08-02
Name
Latest SEC Filings
Name
RCM's Discussions on Twitter

R1 RCM Inc. Stock (RCM) Upgrades & Downgrades

Date Action Analyst Rating Change
Jan-03-24 Initiated Barclays Overweight
Dec-15-23 Upgrade Morgan Stanley Equal-Weight → Overweight
Dec-13-23 Downgrade JP Morgan Overweight → Neutral
Oct-19-23 Upgrade Truist Hold → Buy
Sep-22-23 Initiated Citigroup Buy
Aug-15-23 Initiated Cantor Fitzgerald Overweight
Apr-12-23 Initiated Stephens Overweight
Apr-11-23 Initiated Robert W. Baird Outperform
Feb-02-23 Downgrade Truist Buy → Hold
Jan-05-23 Initiated Canaccord Genuity Buy
Dec-07-22 Upgrade Guggenheim Neutral → Buy
Dec-06-22 Initiated Morgan Stanley Equal-Weight
Oct-24-22 Initiated Evercore ISI Outperform
Sep-16-22 Initiated KeyBanc Capital Markets Overweight
Sep-07-22 Initiated Truist Buy
Aug-01-22 Resumed JP Morgan Overweight
Jun-29-22 Resumed Barclays Overweight
Apr-14-22 Initiated Guggenheim Neutral
Feb-09-22 Initiated Deutsche Bank Buy
Dec-02-21 Initiated Jefferies Buy
Oct-14-21 Initiated JP Morgan Overweight
Sep-30-21 Initiated Barclays Overweight
Jul-22-21 Initiated BofA Securities Buy
Jun-02-21 Initiated Robert W. Baird Outperform
Aug-05-20 Upgrade SVB Leerink Mkt Perform → Outperform
Apr-21-20 Initiated RBC Capital Mkts Outperform
Apr-13-20 Initiated SVB Leerink Mkt Perform
Jan-14-20 Reiterated Dougherty & Company Buy
Jan-10-20 Initiated Dougherty & Company Buy
Jan-22-19 Initiated KeyBanc Capital Mkts Overweight
Dec-10-18 Initiated Citigroup Buy
Sep-04-18 Initiated Chardan Capital Markets Buy
Apr-09-18 Upgrade Robert W. Baird Neutral → Outperform
View All

R1 RCM Inc. Stock (RCM) Financials Data

R1 RCM Inc. (RCM) Revenue 2024

RCM reported a revenue (TTM) of $2.31 billion for the quarter ending March 31, 2024, a +17.61% rise year-over-year.
loading

R1 RCM Inc. (RCM) Net Income 2024

RCM net income (TTM) was -$33.40 million for the quarter ending March 31, 2024, a +63.46% increase year-over-year.
loading

R1 RCM Inc. (RCM) Cash Flow 2024

RCM recorded a free cash flow (TTM) of $228.60 million for the quarter ending March 31, 2024, a +345.81% increase year-over-year.
loading

R1 RCM Inc. (RCM) Earnings per Share 2024

RCM earnings per share (TTM) was -$0.0741 for the quarter ending March 31, 2024, a +69.94% growth year-over-year.
loading
R1 RCM Inc. provides revenue cycle management (RCM) for healthcare providers in the United States. It offers end-to-end RCM services to manage their revenue cycle operations, which encompass patient registration, insurance and benefit verification, medical treatment documentation and coding, and bill preparation and collection from patients and payers. The company also provides modular services comprising physician advisory services, which assists hospitals in complying with payer requirements regarding whether to classify a hospital visit as an in-patient or an out-patient observation case for billing purposes; and revenue capture services, including charge capture, charge description master maintenance, and pricing services. It serves single or multi-hospital healthcare systems, and their respective affiliated ambulatory clinics and physician practice groups. The company was formerly known as Accretive Health, Inc. and changed its name to R1 RCM Inc. in January 2017. R1 RCM Inc. was founded in 2003 and is headquartered in Chicago, Illinois.
$28.08
price down icon 5.96%
health_information_services WAY
$21.62
price down icon 1.73%
health_information_services HQY
$84.37
price up icon 2.29%
$8.39
price down icon 1.41%
$26.71
price down icon 1.00%
Cap:     |  Volume (24h):